期刊文献+

OPN在ⅠA~ⅡA期宫颈癌中的表达及意义

Expression and Significance of OPN in Stage ⅠA~ⅡA Cervical Carcinoma
下载PDF
导出
摘要 目的探讨骨桥蛋白(osteopontin,OPN)在ⅠA~ⅡA期宫颈浸润癌中的表达及其与宫颈癌病理特征的关系和在宫颈癌淋巴结转移中的作用。方法运用链霉菌抗生物素蛋白-过氧化物酶法(SP法)检测44例ⅠA~ⅡA期宫颈浸润癌患者及15例正常宫颈组织的骨桥蛋白水平。结果 (1)44例ⅠA~ⅡA期宫颈癌组织中骨桥蛋白的阳性表达率为72.73%(32/44),高于正常宫颈组织的13.33%(2/15),两组比较差异有统计学意义(P<0.05)。(2)骨桥蛋白的表达在宫颈癌分化程度、组织类型、浸润深度、患者年龄间比较,差异均无统计学意义(P>0.05)。而在ⅠA、ⅠB期与ⅡA期,在小于或等于1个淋巴结转移患者与大于1个淋巴结转移之间患者比较,差异有统计学意义(P<0.05)。结论骨桥蛋白在宫颈癌中呈阳性表达,其阳性表达与临床分期、淋巴结转移数目有关,检测宫颈癌组织骨桥蛋白表达可为预测盆腔淋巴结转移提供帮助。 Objective To investigate the expression levels of osteopontin (OPN) in stage ⅠA~ⅡA cervical carcinoma and to study the pathological characteristics.To discuss their contribution to lympho-metastasis.Methods The expression of OPN was detected in 44 samples of cervical carcinoma with stage ⅠA~ⅡA and 15 samples of normal cervix by using SP method (streptavidin-perosidase,SP) to analyze the correlation with clinical pathological characters,lympho-metastasis and their clinical implication.Results (1)The positive expression rates of OPN was 72.73%(32/44) and 13.33% (2/15) in cervical carcinoma and normal cervix respectively with significant difference(P0.05).(2) The positive expression rates of OPN had no significant in cervical cancer's pathological grades,tissue types,invasive depth and ages(P0.05).But the expression had significant differences in stage Ⅰa,Ⅰb and stage Ⅱa(P0.05).OPN expression in patients with less than or equal one positive lymphonode was different from others with more than one positive lymphonodes(P0.05).Conclusion The positive expression rates of OPN in cervical carcinoma were higher and has significant differences in clinical stages.The positive expression of OPN corelates to amount of positive lymph nodes.The expression of OPN may be helpful to predicte lympho-metstasis.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2010年第12期1409-1412,共4页 Cancer Research on Prevention and Treatment
基金 云南省卫生科技计划项目(2009NS020)
关键词 骨桥蛋白 宫颈肿瘤 转移 Osteopontin Cervical carcinoma Metastasis
  • 相关文献

参考文献14

  • 1Terashi T, Aishima S, Taguchi K, et al. Decreased expression of osteopontin is related to tumor aggressiveness and clinical outcome of intrahepatic cholangiocarcinoma[J]. Liver Int, 2004,24( 1 ) : 38-45.
  • 2程玺,蔡树模,李子庭,唐美琴,薛木泉,臧荣余.宫颈癌根治术后盆腔淋巴结转移的预后研究[J].癌症,2003,22(11):1219-1223. 被引量:17
  • 3Coppola D, Szabo M, Boulware D, et al. Correlation of osteopontin prolein expression and pathological stage across a wide variety of tumor histologies[J]. Clin Cancer Res,2004,11 (1 pt 1):184-190.
  • 4梅慧,濮德敏,侯春梅,塔拉.宫颈癌中骨桥蛋白和CD44v6的表达及临床意义[J].中国组织化学与细胞化学杂志,2007,16(3):278-282. 被引量:7
  • 5Briese J, Schulte HM, Bamberger CM, et al. Expression pattern of osteopontin in endometrial carcinoma: correlation with ex pression of the adhesion molecule CEACAM1 [J]. Int J Gyne col Pathol,2006,25(2): 161-169.
  • 6孙现军,左文述,马恒,侯文红,蔡淑萍,姜希宏.骨桥蛋白mRNA在胃癌中的表达及其临床意义[J].中华肿瘤杂志,2005,27(5):292-295. 被引量:19
  • 7Dai N, Ban Q, Lu A, et al. Protein expression of osteopontin in tumor is an independent prognostic indicator in gastric cancer [J]. Oncology, 2007,72 ( 1 2) : 89-96.
  • 8Cho H, Hong SW, Oh YJ, et al. Clinical significance of osteopontin expression in cervical cancer [J]. J Cancer Res Clin Oncol,2008,134(8):909-917.
  • 9Rittling SR,Chambers AF. Role of osteopontin in tumour Progression [J]. Br J Cancer, 2004,90(10): 1877-1881.
  • 10赵鹏,陆小明,鲁艾林,陈云祥,刘宁,傅震.OPN基因RNAi对U87胶质瘤细胞生长和侵袭的抑制作用[J].中国肿瘤生物治疗杂志,2009,16(4):383-386. 被引量:2

二级参考文献54

  • 1Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression [ J ]. Trends Cell Biol, 2006, 16 (2) : 79-87.
  • 2Rodrigues LR, Teixeira JA, Schmitt FL, et al. The role of osteopontin in tumor progression and metastasis in breast cancer [ J]. Cancer Epidemiol Biomarkers Prev, 2007, 16 (6) : 1087- 1097.
  • 3Chakraborty G, Jain S, Behera R, et al. The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis [J]. Curr Mol Med, 2006, 6(8) : 819-830.
  • 4Zhao J, Dong L, Lu B, et al. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis [ J ]. Gastroenterology, 2008, 135 (3) : 956-968.
  • 5El-Tanani MK, Campbell FC, Kurisetty V, et al. The regulation and role of osteopontin in malignant transformation and cancer [J]. Cytokine Growth Factor Rev, 2006, 17(6) : 463-474.
  • 6Selkirk SM, Morrow J, Barone TA, et al. Elevation of osteopontin levels in brain tumor cells reduces burden and promotes survival through the inhibition of cell dispersal [ J]. J Neurooncol, 2008, 86(3) : 285-296.
  • 7Ui-Tei K, Naito Y, Takahashi F, et al. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference [J]. Nucleic Acids Res, 2004, 32(3): 936-948.
  • 8卢圣栋.现代分子生物学实验技术[M].第2版.北京:中国协和医科大学出版社,2001:400-403.
  • 9Wrensch M, Fisher JL, Schwartzbaum JA, et al. The molecular epidemiology of gliomas in adults [ J]. Neurosurg Focus, 2005, 19 (5): E5.
  • 10Chakravarti A, Palanichamy K. Overcoming therapeutic resistance in malignant gliomas: current practices and future directions [ J]. Cancer Treat Res, 2008, 139(2): 173-189.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部